UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 10 | October 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 7 Issue 5
May-2020
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2005487


Registration ID:
405999

Page Number

1261-1266

Share This Article


Jetir RMS

Title

GINGKO BILOBA ROLE IN PATIENTS WITH ALZHEIMER’S

Abstract

In the treatment of central nervous system and cardiovascular illnesses, Ginkgo biloba extract (GBE) has been extensively employed. A total of 17 preclinical studies and 20 clinical trials examining the therapeutic efficacy of GBE against Alzheimer's disease (AD) were retrieved from electronic sources; however, no systematic review has been undertaken. Meta-analysis of the AD-related pathological characteristics or symptoms was carried out by extracting the data from the reports and conducting Morri’s water maze cognitive function evaluations on 45 animals treated with GBE in six studies. In multiple experiments involving rats and mice, GBE was shown to minimize escape latencies (I2 > 70%, p 0.005). There were eight clinical studies with a total of 2100 participants. GBE increased the SKT and ADAS-Cog scores in early-stage Alzheimer's patients following long-term administration of high dosages and long-term administration. The research has two evident limitations: a lack of sample size calculations and low procedure quality. Preclinical and clinical findings, however, point to the necessity for future large-scale clinical studies in order to explore the effects of long-term GEB treatment on early-stage Alzheimer's disease (AD).

Key Words

Ginkgo biloba extract; Alzheimer’s disease; clinical trial; meta-analysis

Cite This Article

"GINGKO BILOBA ROLE IN PATIENTS WITH ALZHEIMER’S", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.7, Issue 5, page no.1261-1266, May 2020, Available :http://www.jetir.org/papers/JETIR2005487.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"GINGKO BILOBA ROLE IN PATIENTS WITH ALZHEIMER’S", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.7, Issue 5, page no. pp1261-1266, May 2020, Available at : http://www.jetir.org/papers/JETIR2005487.pdf

Publication Details

Published Paper ID: JETIR2005487
Registration ID: 405999
Published In: Volume 7 | Issue 5 | Year May-2020
DOI (Digital Object Identifier):
Page No: 1261-1266
Country: -, -, India .
Area: Engineering
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000265

Print This Page

Current Call For Paper

Jetir RMS